Portfolio-scope analytics over the 655-deal corpus: scorecard (deal count, EV, MOIC/IRR quartiles, loss + home-run rates), vintage cohort breakdown, deal-type mix, subsector / geography / sponsor concentration, and realized-MOIC outliers.
Home-run deals are realized MOIC ≥ 3.0x; loss deals are < 1.0x. Vintage and deal-type medians are colored green ≥ 2.50x, amber ≥ 1.50x, red below. Outliers are deals with |z| ≥ 2 on the realized-MOIC distribution.
Use the vintage cohort to time pacing decisions (which years the corpus is over-weight in) and the concentration panel to stress-test subsector or sponsor single-point risk before committing a new deal.
Portfolio-scope views across the 655-deal corpus. Combines portfolio_analytics (scorecard, vintages, return distribution) with concentration analysis across subsector, geography, and sponsor. For per-sponsor depth see /sponsor-track-record; for payer-mix depth see /payer-intelligence.
| Deal Type | Count | Share % | Med MOIC | Loss % | HR % |
|---|---|---|---|---|---|
| other | 250 | 38.2% | 2.80x | 14.9% | — |
| lbo | 88 | 13.4% | 2.80x | 8.5% | — |
| platform | 68 | 10.4% | 2.80x | 3.4% | — |
| ipo | 59 | 9.0% | 3.00x | 11.5% | — |
| growth_equity | 56 | 8.5% | 3.20x | 13.0% | — |
| merger | 45 | 6.9% | 2.25x | 23.1% | — |
| add_on | 30 | 4.6% | 3.10x | 0.0% | — |
| carve_out | 23 | 3.5% | 2.30x | 0.0% | — |
| distressed | 18 | 2.7% | 0.35x | 80.0% | — |
| spac | 18 | 2.7% | 0.30x | 53.8% | — |
| Vintage | Count | Realized | Med MOIC | Total EV | Loss % | HR % |
|---|---|---|---|---|---|---|
| 1999 | 1 | 1 | 0.50x | $7.50B | 100.0% | 0.0% |
| 2004 | 4 | 4 | 2.80x | $4.46B | 0.0% | 50.0% |
| 2005 | 3 | 3 | 2.80x | $6.65B | 0.0% | 33.3% |
| 2006 | 3 | 2 | 2.25x | $33.97B | 0.0% | 0.0% |
| 2007 | 2 | 2 | 4.15x | $1.39B | 0.0% | 100.0% |
| 2009 | 1 | 1 | 2.60x | $1.05B | 0.0% | 0.0% |
| 2010 | 9 | 7 | 0.80x | $10.72B | 57.1% | 28.6% |
| 2011 | 13 | 12 | 3.90x | $9.57B | 0.0% | 91.7% |
| 2012 | 6 | 3 | 4.20x | $10.66B | 0.0% | 100.0% |
| 2013 | 5 | 4 | 2.55x | $6.43B | 25.0% | 25.0% |
| 2014 | 22 | 18 | 2.80x | $39.08B | 11.1% | 38.9% |
| 2015 | 36 | 29 | 2.80x | $48.23B | 3.4% | 37.9% |
| 2016 | 39 | 33 | 2.40x | $108.50B | 21.2% | 36.4% |
| 2017 | 31 | 25 | 3.10x | $32.00B | 0.0% | 60.0% |
| 2018 | 67 | 50 | 2.80x | $239.19B | 16.0% | 46.0% |
| 2019 | 77 | 56 | 3.00x | $130.19B | 3.6% | 51.8% |
| 2020 | 78 | 37 | 2.80x | $168.59B | 13.5% | 40.5% |
| 2021 | 117 | 44 | 2.45x | $251.78B | 29.5% | 38.6% |
| 2022 | 63 | 5 | 1.20x | $160.85B | 40.0% | 0.0% |
| 2023 | 32 | 6 | 1.05x | $91.59B | 50.0% | 16.7% |
| 2024 | 6 | 2 | 1.75x | $14.60B | 0.0% | 0.0% |
| Subsector | Count | Share | |
|---|---|---|---|
| health_it | 44 | 12.9% | |
| managed_care | 32 | 9.4% | |
| physician_group | 22 | 6.5% | |
| hospital | 16 | 4.7% | |
| behavioral_health | 15 | 4.4% | |
| home_health | 13 | 3.8% | |
| asc | 9 | 2.6% | |
| oncology | 8 | 2.4% | |
| dialysis | 7 | 2.1% | |
| dme_home_health | 6 | 1.8% |
| State / Region | Count | Share | |
|---|---|---|---|
| CA | 12 | 17.1% | |
| TN | 10 | 14.3% | |
| PA | 7 | 10.0% | |
| FL | 6 | 8.6% | |
| IL | 4 | 5.7% | |
| NY | 4 | 5.7% | |
| VA | 3 | 4.3% | |
| MA | 3 | 4.3% | |
| CO | 3 | 4.3% | |
| OH | 2 | 2.9% |
| Sponsor | Deals | Total EV | Share |
|---|---|---|---|
| KKR | 22 | $72.89B | 5.0% |
| Cigna Group | 1 | $67.00B | 4.6% |
| UnitedHealth Group / Optum | 12 | $60.83B | 4.2% |
| Centene Corporation | 4 | $36.97B | 2.5% |
| KKR / Bain Capital / Merrill Lynch PE | 1 | $33.00B | 2.3% |
| Public Market (IPO) | 5 | $29.70B | 2.0% |
| CommonSpirit Health (combined non-profit) | 1 | $29.00B | 2.0% |
| CVS Health | 4 | $26.77B | 1.8% |
| Veritas Capital | 4 | $23.70B | 1.6% |
| Blackstone Group | 6 | $22.27B | 1.5% |
| Deal | Year | Realized MOIC | Z-score |
|---|---|---|---|
| Acadia Healthcare – Waud Capital Build-up | 2011 | 12.50x | — |
| Iora Health / One Medical Acquisition | 2021 | 9.00x | — |
| Smile Direct Club – Camelot Venture Group seed | 2014 | 8.50x | — |
| Acadia Healthcare Behavioral Health IPO | 2011 | 8.20x | — |
| Acadia Healthcare / Waud Capital LBO | 2011 | 8.20x | — |
| Ciox Health / Datavant Merger | 2021 | 8.00x | — |
| Landmark Health / UnitedHealth Group | 2021 | 7.00x | — |
| AccordantHealth / Humana spinout (Evolent Health predecessor) | 2011 | 6.00x | — |